| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 4,686,000 | 5,206,000 | 4,857,000 | 4,880,000 | | Cost of Revenue | 314,000 | 324,000 | 392,000 | 425,000 | | | Gross Profit | 4,372,000 | 4,882,000 | 4,465,000 | 4,455,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,129,000 | 1,871,000 | 1,960,000 | 1,823,000 | | Non Recurring | 342,000 |
-
|
-
|
-
| | Others | 844,000 | 1,869,000 | 1,520,000 | 1,159,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,057,000 | 1,142,000 | 985,000 | 1,473,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,057,000 | 1,142,000 | 985,000 | 1,473,000 | | Interest Expense | 472,000 | 496,000 | 628,000 | 699,000 | | Income Before Tax | 585,000 | 646,000 | 357,000 | 774,000 | | Income Tax Expense | 100,000 | 101,000 | 27,000 | 198,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 485,000 | 545,000 | 330,000 | 576,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 485,000 | 545,000 | 330,000 | 576,000 | | Preferred Stock And Other Adjustments | (374,000) | (16,000) | (70,000) | (19,000) | | | Net Income Applicable To Common Shares | $111,000 | $529,000 | $260,000 | $557,000 |
|
2.03% Nasdaq 0.00%
Income Statement
